MASITINIB + ISOQUERCETIN IN COVID-19
11 MAY 2020
MASITINIB IN PRIMARY PROGRESSIVE AND NON-ACTIVE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
06 MARCH 2020
MASITINIB IN INDOLENT SYSTEMIC MASTOCYTOSIS
20 NOVEMBER 2019
MASITINIB IN SEVERE ASTHMA UNCONTROLLED BY ORAL COTICOSTEROIDS
02 DECEMBER 2019